ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,969.52
-0.17%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.675
0.00%
Brent Oil
83.76
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Clementia Pharmaceuticals Inc. (CMTA)

  7. Clementia Pharmaceuticals Inc. (CMTA) ニュース

CMTA

Clementia Pharmaceuticals Inc. (CMTA)

Clementia Pharmaceuticals Inc.
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CMTA
日付受信時刻ニュースソース見出しコード企業名
2019/08/1521 : 30GlobeNewswire Inc.Accomplished Financial Executive, Steve Forte, Joins Profound Medical’s BoardNASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/2921 : 28Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1919 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1822 : 11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1821 : 05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1821 : 04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1821 : 02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1201 : 01Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1201 : 00GlobeNewswire Inc.Clementia Pharmaceuticals Inc. Announces Receipt of Final Court Approval for Plan of Arrangement With Ipsen S.A.NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1001 : 40Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/04/1001 : 29GlobeNewswire Inc.Clementia Pharmaceuticals Inc. Shareholders Approve Plan of Arrangement With Ipsen S.A.NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/3006 : 09Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/1322 : 02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/1320 : 24Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0804 : 59PR Newswire (US)Clementia Pharmaceuticals Inc. Obtains Interim Order for Proposed Transaction With Ipsen S.A. and Enters Into Support and Vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0804 : 55PR Newswire (US)Clementia Pharmaceuticals Inc. Obtains Interim Order for Proposed Transaction With Ipsen S.A. and Enters Into Support and Vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0803 : 25PR Newswire (Canada)Clementia Pharmaceutiques Inc. obtient une ordonnance provisoire pour la transaction proposée avec Ipsen S.A. et conclut des...NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0803 : 00PR Newswire (US)Clementia Pharmaceuticals Inc. obtains interim order for proposed transaction with Ipsen S.A. and enters into support and vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0803 : 00PR Newswire (Canada)Clementia Pharmaceuticals Inc. obtains interim order for proposed transaction with Ipsen S.A. and enters into support and vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0706 : 50Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0706 : 37Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0706 : 01PR Newswire (Canada)Clementia Pharmaceuticals Inc. obtains interim order for proposed transaction with Ipsen S.A. and enters into support and vot...NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0706 : 01PR Newswire (Canada)Clementia Pharmaceutiques Inc. obtient une ordonnance provisoire pour la transaction proposée avec Ipsen S.A. et conclut des...NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0206 : 03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0204 : 15PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Clementia Pharmaceuticals, Inc.NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/03/0101 : 55Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/02/2620 : 32Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/02/2620 : 30GlobeNewswire Inc.Clementia Announces Cancellation of Fourth Quarter and Year-End 2018 Financial Results and Conference CallNASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/02/2606 : 26Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
2019/02/2522 : 11Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CMTAClementia Pharmaceuticals Inc.
 Showing the most relevant articles for your search:NASDAQ:CMTA

最近閲覧した銘柄

LSE
REVB
Revolution Beauty
TSXV
EST
LSE
JUB
NASDAQ
DEACU
Diamond Eagle Acquisition
BIT
P15IT4
BNP Paribas Issuance
BIT
I06573
Banca Imi
BIT
S27022
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有